Molecular Profiling of Innate Immune Response Mechanisms in Ventilator-Associated 2 Pneumonia
Total Page:16
File Type:pdf, Size:1020Kb
bioRxiv preprint doi: https://doi.org/10.1101/2020.01.08.899294; this version posted January 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Title: Molecular profiling of innate immune response mechanisms in ventilator-associated 2 pneumonia 3 Authors: Khyatiben V. Pathak1*, Marissa I. McGilvrey1*, Charles K. Hu3, Krystine Garcia- 4 Mansfield1, Karen Lewandoski2, Zahra Eftekhari4, Yate-Ching Yuan5, Frederic Zenhausern2,3,6, 5 Emmanuel Menashi3, Patrick Pirrotte1 6 *These authors contributed equally to this work 7 Affiliations: 8 1. Collaborative Center for Translational Mass Spectrometry, Translational Genomics Research 9 Institute, Phoenix, Arizona 85004 10 2. Translational Genomics Research Institute, Phoenix, Arizona 85004 11 3. HonorHealth Clinical Research Institute, Scottsdale, Arizona 85258 12 4. Applied AI and Data Science, City of Hope Medical Center, Duarte, California 91010 13 5. Center for Informatics, City of Hope Medical Center, Duarte, California 91010 14 6. Center for Applied NanoBioscience and Medicine, University of Arizona, Phoenix, Arizona 15 85004 16 Corresponding author: 17 Dr. Patrick Pirrotte 18 Collaborative Center for Translational Mass Spectrometry 19 Translational Genomics Research Institute 20 445 North 5th Street, Phoenix, AZ, 85004 21 Tel: 602-343-8454; 22 [[email protected]] 23 Running Title: Innate immune response in ventilator-associated pneumonia 24 Key words: ventilator-associated pneumonia; endotracheal aspirate; proteome, metabolome; 25 neutrophil degranulation 26 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.08.899294; this version posted January 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 27 Abbreviations: AK2: Adenylate kinase 2, BAL: Bronchoalveolar Lavage Fluid, CA1: Carbonic 28 anhydrase 1, CA2: Carbonic anhydrase 2, CRP: C-reactive protein, ECM: Extracellular Matrix, 29 ELANE: Neutrophil elastase, ETA: Endotracheal Aspirates, HAI: Hospital Acquired Infection, 30 HBB: Hemoglobin subunit beta, HBA: Hemoglobin subunit alpha, HBD: Hemoglobin subunit 31 delta, ICU: Intensive Care Unit, MMP9: Matrix metalloproteinase-9, MPO: Myeloperoxidase, 32 MRSA: Methicillin Resistant Staphylococcus aureus, MSSA: Methicillin Sensitive 33 Staphylococcus aureus, NET: Neutrophil extracellular trap, NME-1: Isoform 2 of nucleoside 34 diphosphate kinase A, PRDX1: Peroxiredoxin-1, PRDX2: Peroxiredoxin-2, PRDX6: 35 Peroxiredoxin-6, ROS: Reactive oxygen species, STOM: Erythrocyte band 7 integral membrane 36 protein, VAP: Ventilator-Associated Pneumonia 37 38 2 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.08.899294; this version posted January 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 39 Abstract 40 Ventilator-associated pneumonia (VAP) is a common hospital-acquired infection, leading to high 41 morbidity and mortality. Currently, bronchoalveolar lavage (BAL) is utilized in hospitals for VAP 42 diagnosis and guiding treatment options. While BAL collection procedures are invasive, 43 alternatives such as endotracheal aspirates (ETA) may be of diagnostic value, however, their utility 44 has not been thoroughly explored. Longitudinal ETA and BAL were collected from 16 intubated 45 patients up to 15 days, of which 11 developed VAP. We conducted a comprehensive LC-MS/MS 46 based proteome and metabolome characterization of longitudinal ETA and BAL to detect host and 47 pathogen responses to VAP infection. We discovered a diverse ETA proteome of the upper airways 48 reflective of a rich and dynamic host-microbe interface. Prior to VAP diagnosis by microbial 49 cultures from BAL, patient ETA presented characteristic signatures of reactive oxygen species and 50 neutrophil degranulation, indicative of neutrophil mediated pathogen processing as a key host 51 response to the VAP infection. Along with an increase in amino acids, this is suggestive of 52 extracellular membrane degradation resulting from proteolytic activity of neutrophil proteases. 53 Days prior to VAP diagnosis, detection of pathogen peptides with species level specificity in ETA 54 may increase specificity over culture-based diagnosis. Our findings suggest that ETA may provide 55 early mechanistic insights into host-pathogen interactions associated with VAP infection and 56 therefore facilitate its diagnosis and treatment. 57 3 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.08.899294; this version posted January 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 58 Introduction 59 Ventilator-associated pneumonia (VAP) is the second most common hospital-acquired infection 60 (HAI) in intensive care units (ICU), and is associated to 60% of all HAI-related deaths in the 61 United States (1). It occurs 48 hours after mechanical ventilation and accounts for more than 62 300,000 cases annually in the US. (1, 2). Mechanical ventilation can injure tracheal epithelia, and 63 promote environmental microbial colonization and migration from the upper to lower airways (3). 64 All ICU patients with prolonged hospitalization are at high risk of developing VAP, increasing the 65 cost of hospital stay by $40,000 to $50,000 per patient (3-5). VAP diagnosis is largely based on 66 clinical criteria such as fever, infiltrate on chest radiograph, leukocyte counts, and positive cultures 67 from bronchoalveolar lavages (BAL) (2, 6). With trauma patients, these symptoms are often non- 68 specific and lead to overestimation of true VAP episodes resulting in the prescription of inadequate 69 broad-spectrum antibiotics (6, 7). A study involving 300 U.S. hospitals showed a 52% increase in 70 antibiotic consumption rate in intensive care unit (ICU) compared to non-critical care (8). In 71 addition, VAP accounts for over half of the antibiotics used in the ICU which may lead to multi- 72 drug resistance (9). Culture-based testing can reduce antibiotic misuse, but it is time-consuming 73 and can delay diagnosis and treatment. Therefore, careful investigation of VAP pathogenesis is 74 required to better understand host response to microbial dysbiosis and provide insights into the 75 molecular mechanisms underlying the progression of infection. 76 Previous studies have proposed several candidate biomarkers (interleukin-1β, interleukin-8, 77 soluble triggering receptor expressed on myeloid cells type 1, C-reactive protein (CRP), 78 procalcitonin, and the mid-region fragment of pro-adrenomedullin) to assist VAP diagnosis in 79 serum, plasma or BAL (10-13). Of these, interleukin-1β and interleukin-8 have been successfully 80 validated in VAP diagnosis (13). Also, most of these proteins are inflammation markers and have 4 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.08.899294; this version posted January 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 81 shown variable sensitivity and specificity towards VAP detection (12, 14). This raises potential 82 issues of misdiagnosis and emphasizes the need for further research on specific VAP biomarkers. 83 BAL has been a widely accepted matrix to study pulmonary infections (15, 16). Many studies have 84 demonstrated the utility of BAL for microbial culture, 16S rDNA analysis and determining host- 85 response against VAP infection (16-19). Endotracheal aspirate (ETA) is regarded as a source for 86 non-invasive respiratory sampling and recently has been recommended for semi quantitative 87 cultures in VAP diagnosis (20). However, the molecular composition of ETA has not been 88 explored as extensively as BAL to understand host responses to infection. We hypothesize that 89 reduced invasiveness involved in ETA sampling is permissive to more frequent longitudinal 90 molecular snapshots of host immune response and changes to microbial flora during early 91 infection. We anticipate that this enhanced granularity provides valuable mechanistic insights into 92 VAP pathogenesis. We used a multi-disciplinary approach integrating proteomics and quantitative 93 metabolomics on longitudinal ETA and matched BAL collected from intubated patients for this 94 study. 95 Experimental Procedures 96 Chemicals 97 Chemicals and solvents were procured from Sigma-Aldrich (St. Lois, MO) or Fisher Scientific 98 (San Jose, CA) unless otherwise stated. The chemicals used in this study were AR grade, and the 99 formic acid (FA) and solvents were LC-MS grade. 100 Specimen collections 101 Patients under mechanical ventilation at the ICU trauma center at HonorHealth Osborne Medical 102 Center, Scottsdale, AZ were enrolled for this study. A written informed consent was obtained from 5 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.08.899294; this version posted January 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 103 either patient or a legal relative. The clinical protocol for sample collection was approved by the 104 hospital’s Institutional Review Board and the Western Institutional Review Board, Puyallup,